Q1 EPS Forecast for Phibro Animal Health Raised by Analyst

Phibro Animal Health Corporation (NASDAQ:PAHC) – Equities research analysts at Zacks Research boosted their Q1 2026 EPS estimates for Phibro Animal Health in a note issued to investors on Wednesday, June 18th. Zacks Research analyst R. Department now expects that the company will post earnings of $0.32 per share for the quarter, up from their prior estimate of $0.31. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q2 2026 earnings at $0.59 EPS, Q3 2026 earnings at $0.60 EPS, FY2026 earnings at $2.18 EPS, Q1 2027 earnings at $0.54 EPS and Q2 2027 earnings at $0.58 EPS.

A number of other research analysts have also recently weighed in on the stock. BNP Paribas Exane raised shares of Phibro Animal Health from an “underperform” rating to a “neutral” rating and set a $24.00 price target on the stock in a research report on Monday. BNP Paribas raised shares of Phibro Animal Health to a “hold” rating in a research report on Monday. Morgan Stanley lifted their price target on shares of Phibro Animal Health from $20.00 to $21.00 and gave the company an “equal weight” rating in a research report on Thursday, May 8th. Finally, Wall Street Zen raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Friday, May 9th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, Phibro Animal Health has a consensus rating of “Hold” and a consensus target price of $20.80.

Phibro Animal Health Trading Down 2.0%

Shares of PAHC stock opened at $23.96 on Thursday. The stock has a market cap of $971.10 million, a price-to-earnings ratio of 30.72, a price-to-earnings-growth ratio of 0.45 and a beta of 0.74. The company has a quick ratio of 1.23, a current ratio of 2.91 and a debt-to-equity ratio of 2.67. Phibro Animal Health has a fifty-two week low of $16.16 and a fifty-two week high of $26.55. The firm’s 50 day moving average price is $21.59 and its two-hundred day moving average price is $21.92.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.52 by $0.11. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. The firm had revenue of $347.80 million during the quarter, compared to the consensus estimate of $352.41 million.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in PAHC. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Phibro Animal Health during the fourth quarter worth $29,000. National Bank of Canada FI acquired a new position in shares of Phibro Animal Health during the first quarter worth $30,000. Lazard Asset Management LLC lifted its position in shares of Phibro Animal Health by 2,739.7% during the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company’s stock worth $34,000 after purchasing an additional 1,589 shares in the last quarter. Aquatic Capital Management LLC acquired a new position in shares of Phibro Animal Health during the fourth quarter worth $69,000. Finally, Virtus Fund Advisers LLC acquired a new position in shares of Phibro Animal Health during the fourth quarter worth $69,000. 99.34% of the stock is owned by institutional investors and hedge funds.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be given a dividend of $0.12 per share. The ex-dividend date is Wednesday, June 4th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.00%. Phibro Animal Health’s payout ratio is currently 61.54%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.